NR3C1 and chronic obstructive pulmonary disease: Inhaled long-acting 2 agonists have been observed to increase the nuclear translocation of glucocorticoid receptors in individuals with COPD, and inhaled bronchodilators may have a synergistic effect on inhaled glucocorticoids.[56] This can be one of the factors contributing to ICS’s increased risk of fracture.